Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate → 5-(2,6-Dichloro-phenylmethanesulfonyl)-3-[1-{3,5-dimethyl-4-[2-(4-morpholin-4-yl-piperidin-1-yl)-2-oxo-ethyl]-1h-pyrrol-2-yl}-meth-(z)-ylidene]-1,3-dihydro-indol-2-one
反応式
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[C:4]([Cl:8])[C:3]=1[CH2:9][S:10]([C:13]1[CH:14]=[C:15]2[C:19](=[CH:20][CH:21]=1)[NH:18][C:17](=[O:22])/[C:16]/2=[CH:23]\[C:24]1[NH:28][C:27]([CH3:29])=[C:26]([CH2:30][C:31](O)=[O:32])[C:25]=1[CH3:34])(=[O:12])=[O:11].F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1.[NH:62]1[CH2:67][CH2:66][CH:65]([N:68]2[CH2:73][CH2:72][O:71][CH2:70][CH2:69]2)[CH2:64][CH2:63]1.[Li+].[Cl-]>CN(C=O)C.C(Cl)(Cl)Cl.C(O)(C)C>[Cl:8][C:4]1[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[C:3]=1[CH2:9][S:10]([C:13]1[CH:14]=[C:15]2[C:19](=[CH:20][CH:21]=1)[NH:18][C:17](=[O:22])/[C:16]/2=[CH:23]\[C:24]1[NH:28][C:27]([CH3:29])=[C:26]([CH2:30][C:31]([N:62]2[CH2:67][CH2:66][CH:65]([N:68]3[CH2:73][CH2:72][O:71][CH2:70][CH2:69]3)[CH2:64][CH2:63]2)=[O:32])[C:25]=1[CH3:34])(=[O:11])=[O:12]参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
{5-[5-(2,6-dichloro-phenylmethanesulfonyl)-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrol-3-yl}-acetic acid (1 eq.) and BOP (1.25 eq.) were suspended in DMF (5 mL) at rt and TEA (2.4 eq.) was added. After 15 mins, to the homogenous reaction mixture was added 4-piperidin-4-yl-morpholine (1.25 eq.) all at once. After stirring for 2 days, the reaction was added to a mixture of chloroform-isopropanol (5:1) and 5% aq. LiCl. The organic layer was separated, washed with 5% aq. LiCl (2×), 1 M aq. NaOH (3×), brine, dried and concentrated. The residue was purified to give the titled compound.
後処理
- customThe organic layer was separated
- washwashed with 5% aq. LiCl (2×), 1 M aq. NaOH (3×), brine
- customdried
- concentrationconcentrated
- customThe residue was purified
出典と根拠
- ORDレコード
- ord-bf3493ac74a34398ba97a224afa7cc62
- 出典データセット
- uspto-grants-2003_07
- 特許番号
- US06599902B2
反応ノート
読み込み中…